|
2026-11-17 |
2026-11-16 |
S
Sale
|
Chief Financial Officer
Officer
|
22,161
-0.3%
384.11
US$84,252
|
22,161
-0.3%
|
384.11
|
US$84,252
|
|
|
2026-11-16 |
2026-11-16 |
PrS
Proposed sale
|
Officer
Officer
|
15,034
335.02
US$2,970,696
|
15,034
|
335.02
|
US$2,970,696
|
|
|
2026-10-20 |
2026-10-20 |
PlS
Planned sale
|
Chief Legal Officer
Officer
|
34,314
-20.4%
267.53
US$1,130,487
|
34,314
-20.4%
|
267.53
|
US$1,130,487
|
|
|
2026-10-20 |
2026-10-20 |
PrS
Proposed sale
|
Officer
Officer
|
19,275
4.44
US$85,581
|
19,275
|
4.44
|
US$85,581
|
|
|
2026-10-20 |
2026-10-19 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
4,066
-0.1%
4.41
US$17,931
|
4,066
-0.1%
|
4.41
|
US$17,931
|
|
|
2026-10-19 |
2026-10-19 |
PrS
Proposed sale
|
Officer
Officer
|
4,066
4.48
US$18,216
|
4,066
|
4.48
|
US$18,216
|
|
|
2026-10-19 |
2026-10-15 |
S
Sale
|
Chief Executive Officer
Executive Director
|
62,176
-0.7%
4.68
US$290,984
|
62,176
-0.7%
|
4.68
|
US$290,984
|
|
|
2026-10-19 |
2026-10-15 |
S
Sale
|
Chief Legal Officer
Officer
|
14,673
-0.9%
4.68
US$68,670
|
14,673
-0.9%
|
4.68
|
US$68,670
|
|
|
2026-10-19 |
2026-10-15 |
S
Sale
|
Interim CFO
Officer
|
4,591
-0.4%
4.68
US$21,486
|
4,591
-0.4%
|
4.68
|
US$21,486
|
|
|
2026-10-19 |
2026-10-15 |
S
Sale
|
CEO, Counterpart Health
Officer
|
23,627
-2.2%
4.68
US$110,574
|
23,627
-2.2%
|
4.68
|
US$110,574
|
|
|
2026-10-19 |
2026-10-15 |
S
Sale
|
CEO, Medicare Advantage
Officer
|
18,273
-0.7%
4.68
US$85,518
|
18,273
-0.7%
|
4.68
|
US$85,518
|
|
|
2026-10-15 |
2026-10-15 |
PrS
Proposed sale
|
Officer
Officer
|
60,765
4.68
US$284,380
|
60,765
|
4.68
|
US$284,380
|
|
|
2026-10-15 |
2026-10-15 |
PrS
Proposed sale
|
Officer
Officer
|
4,487
4.68
US$20,999
|
4,487
|
4.68
|
US$20,999
|
|
|
2026-10-15 |
2026-10-15 |
PrS
Proposed sale
|
Officer
Officer
|
23,463
4.68
US$109,807
|
23,463
|
4.68
|
US$109,807
|
|
|
2026-10-15 |
2026-10-15 |
PrS
Proposed sale
|
Officer
Officer
|
14,341
4.68
US$67,116
|
14,341
|
4.68
|
US$67,116
|
|
|
2026-10-15 |
2026-10-15 |
PrS
Proposed sale
|
Officer
Officer
|
17,858
4.68
US$83,575
|
17,858
|
4.68
|
US$83,575
|
|
|
2026-10-07 |
2026-10-07 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
2,006
-0.1%
4.63
US$9,288
|
2,006
-0.1%
|
4.63
|
US$9,288
|
|
|
2026-10-07 |
2026-10-07 |
PrS
Proposed sale
|
Officer
Officer
|
2,006
4.60
US$9,228
|
2,006
|
4.60
|
US$9,228
|
|
|
2026-10-05 |
2026-10-05 |
S
Sale
|
CEO, Medicare Advantage
Officer
|
8,750
-0.3%
4.42
US$38,675
|
8,750
-0.3%
|
4.42
|
US$38,675
|
|
|
2026-10-05 |
2026-10-05 |
PrS
Proposed sale
|
Officer
Officer
|
8,706
4.68
US$40,744
|
8,706
|
4.68
|
US$40,744
|
|
|
2026-10-02 |
2026-10-01 |
S
Sale
|
Chief Executive Officer
Executive Director
|
318,806
-3.4%
4.19
US$1,335,797
|
318,806
-3.4%
|
4.19
|
US$1,335,797
|
|
|
2026-10-01 |
2026-10-01 |
PrS
Proposed sale
|
Officer
Officer
|
309,558
4.23
US$1,309,430
|
309,558
|
4.23
|
US$1,309,430
|
|
|
2026-09-24 |
2026-09-24 |
PrS
Proposed sale
|
Former Officer
Officer
|
141,418
4.46
US$631,163
|
141,418
|
4.46
|
US$631,163
|
|
|
2026-09-18 |
2026-09-17 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
1,921
-0.1%
4.56
US$8,760
|
1,921
-0.1%
|
4.56
|
US$8,760
|
|
|
2026-09-17 |
2026-09-17 |
PrS
Proposed sale
|
Officer
Officer
|
1,921
4.56
US$8,760
|
1,921
|
4.56
|
US$8,760
|
|
|
2026-09-17 |
2026-09-16 |
S
Sale
|
VP OF FINANCE AND CONTROLLER
Officer
|
3,170
-1.1%
4.64
US$14,709
|
3,170
-1.1%
|
4.64
|
US$14,709
|
|
|
2026-09-16 |
2026-09-16 |
PrS
Proposed sale
|
Officer
Officer
|
3,170
4.64
US$14,709
|
3,170
|
4.64
|
US$14,709
|
|
|
2026-09-16 |
2026-09-15 |
PlS
Planned sale
|
CEO, Counterpart Health
Officer
|
300,000
-20.4%
4.72
US$1,416,000
|
300,000
-20.4%
|
4.72
|
US$1,416,000
|
|
|
2026-09-15 |
2026-09-15 |
S
Sale
|
Chief Legal Officer
Officer
|
6,846
-0.4%
4.78
US$32,724
|
6,846
-0.4%
|
4.78
|
US$32,724
|
|
|
2026-09-15 |
2026-09-15 |
S
Sale
|
CEO, Medicare Advantage
Officer
|
9,273
-0.3%
4.78
US$44,325
|
9,273
-0.3%
|
4.78
|
US$44,325
|
|
|
2026-09-15 |
2026-09-15 |
PrS
Proposed sale
|
Officer
Officer
|
6,416
4.66
US$29,899
|
6,416
|
4.66
|
US$29,899
|
|
|
2026-09-15 |
2026-09-15 |
PrS
Proposed sale
|
Officer
Officer
|
8,691
4.66
US$40,500
|
8,691
|
4.66
|
US$40,500
|
|
|
2026-09-15 |
2026-09-15 |
PrS
Proposed sale
|
Former Officer
Officer
|
215,291
4.64
US$999,575
|
215,291
|
4.64
|
US$999,575
|
|
|
2026-09-15 |
2026-09-15 |
PrS
Proposed sale
|
Officer
Officer
|
300,000
4.72
US$1,417,022
|
300,000
|
4.72
|
US$1,417,022
|
|
|
2026-09-14 |
2026-09-14 |
S
Sale
|
VP OF FINANCE AND CONTROLLER
Officer
|
20,000
-6.7%
5.16
US$103,200
|
20,000
-6.7%
|
5.16
|
US$103,200
|
|
|
2026-09-14 |
2026-09-14 |
PrS
Proposed sale
|
Officer
Officer
|
20,000
5.16
US$103,100
|
20,000
|
5.16
|
US$103,100
|
|
|
2026-08-31 |
2026-08-31 |
PrS
Proposed sale
|
Officer
Officer
|
73,516
4.15
US$305,113
|
73,516
|
4.15
|
US$305,113
|
|
|
2026-08-17 |
2026-08-17 |
S
Sale
|
Interim CFO
Officer
|
17,775
-1.4%
4.39
US$78,032
|
17,775
-1.4%
|
4.39
|
US$78,032
|
|
|
2026-08-17 |
2026-08-17 |
PrS
Proposed sale
|
Officer
Officer
|
16,942
4.27
US$72,342
|
16,942
|
4.27
|
US$72,342
|
|
|
2026-08-14 |
2026-08-14 |
PrS
Proposed sale
|
Officer
Officer
|
474,801
4.57
US$2,171,597
|
474,801
|
4.57
|
US$2,171,597
|
|
|
2026-08-10 |
2026-08-10 |
S
Sale
|
Chief Executive Officer
Executive Director
|
87,798
-0.9%
4.65
US$408,261
|
87,798
-0.9%
|
4.65
|
US$408,261
|
|
|
2026-08-10 |
2026-08-10 |
PrS
Proposed sale
|
Officer
Officer
|
85,704
4.57
US$391,667
|
85,704
|
4.57
|
US$391,667
|
|
|
2026-08-07 |
2026-08-07 |
PrS
Proposed sale
|
Officer
Officer
|
441,601
4.85
US$2,141,989
|
441,601
|
4.85
|
US$2,141,989
|
|
|
2026-07-20 |
2026-07-20 |
PlS
Planned sale
|
Chief Legal Officer
Officer
|
51,700
-3.3%
4.51
US$233,167
|
51,700
-3.3%
|
4.51
|
US$233,167
|
|
|
2026-07-20 |
2026-07-20 |
PrS
Proposed sale
|
Officer
Officer
|
51,700
4.62
US$238,854
|
51,700
|
4.62
|
US$238,854
|
|
|
2026-07-17 |
2026-07-17 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
4,839
-0.2%
4.53
US$21,921
|
4,839
-0.2%
|
4.53
|
US$21,921
|
|
|
2026-07-17 |
2026-07-17 |
PrS
Proposed sale
|
Officer
Officer
|
4,839
4.40
US$21,292
|
4,839
|
4.40
|
US$21,292
|
|
|
2026-07-16 |
2026-07-15 |
S
Sale
|
Chief Executive Officer
Executive Director
|
62,711
-0.7%
4.67
US$292,860
|
62,711
-0.7%
|
4.67
|
US$292,860
|
|
|
2026-07-16 |
2026-07-15 |
S
Sale
|
CEO, Counterpart Health
Officer
|
24,215
-2.1%
4.67
US$113,084
|
24,215
-2.1%
|
4.67
|
US$113,084
|
|
|
2026-07-16 |
2026-07-15 |
S
Sale
|
CEO, Medicare Advantage
Officer
|
13,119
-0.5%
4.67
US$61,266
|
13,119
-0.5%
|
4.67
|
US$61,266
|
|
|
2026-07-16 |
2026-07-15 |
S
Sale
|
Chief Legal Officer
Officer
|
10,519
-0.7%
4.67
US$49,124
|
10,519
-0.7%
|
4.67
|
US$49,124
|
|
|
2026-07-16 |
2026-07-15 |
S
Sale
|
Interim CFO
Officer
|
4,630
-0.4%
4.67
US$21,622
|
4,630
-0.4%
|
4.67
|
US$21,622
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
4,486
4.68
US$20,994
|
4,486
|
4.68
|
US$20,994
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
10,192
4.68
US$47,699
|
10,192
|
4.68
|
US$47,699
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
12,712
4.68
US$59,492
|
12,712
|
4.68
|
US$59,492
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
60,765
4.68
US$284,380
|
60,765
|
4.68
|
US$284,380
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
23,463
4.68
US$109,807
|
23,463
|
4.68
|
US$109,807
|
|
|
2026-07-09 |
2026-07-08 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
2,384
-0.1%
4.68
US$11,157
|
2,384
-0.1%
|
4.68
|
US$11,157
|
|
|
2026-07-08 |
2026-07-08 |
PrS
Proposed sale
|
Officer
Officer
|
2,384
5.00
US$11,920
|
2,384
|
5.00
|
US$11,920
|
|
|
2026-07-06 |
2026-07-06 |
S
Sale
|
CEO, Medicare Advantage
Officer
|
6,229
-0.2%
5.26
US$32,765
|
6,229
-0.2%
|
5.26
|
US$32,765
|
|
|
2026-07-06 |
2026-07-06 |
PrS
Proposed sale
|
Officer
Officer
|
6,229
5.26
US$32,765
|
6,229
|
5.26
|
US$32,765
|
|
|
2026-07-01 |
2026-07-01 |
S
Sale
|
Chief Executive Officer
Executive Director
|
313,476
-3.2%
5.32
US$1,667,692
|
313,476
-3.2%
|
5.32
|
US$1,667,692
|
|
|
2026-07-01 |
2026-07-01 |
PrS
Proposed sale
|
Officer
Officer
|
309,558
5.39
US$1,668,518
|
309,558
|
5.39
|
US$1,668,518
|
|
|
2026-06-18 |
2026-06-17 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
2,360
-0.1%
4.78
US$11,281
|
2,360
-0.1%
|
4.78
|
US$11,281
|
|
|
2026-06-17 |
2026-06-17 |
PrS
Proposed sale
|
Officer
Officer
|
2,360
4.94
US$11,658
|
2,360
|
4.94
|
US$11,658
|
|
|
2026-06-17 |
2026-06-16 |
S
Sale
|
VP OF FINANCE AND CONTROLLER
Officer
|
12,102
-3.9%
4.86
US$58,816
|
12,102
-3.9%
|
4.86
|
US$58,816
|
|
|
2026-06-16 |
2026-06-16 |
PrS
Proposed sale
|
Officer
Officer
|
14,155
4.94
US$69,926
|
14,155
|
4.94
|
US$69,926
|
|
|
2026-06-16 |
2026-06-15 |
S
Sale
|
Chief Legal Officer
Officer
|
4,681
-0.3%
4.61
US$21,579
|
4,681
-0.3%
|
4.61
|
US$21,579
|
|
|
2026-06-16 |
2026-06-15 |
S
Sale
|
CEO, Medicare Advantage
Officer
|
6,350
-0.2%
4.61
US$29,274
|
6,350
-0.2%
|
4.61
|
US$29,274
|
|
|
2026-06-15 |
2026-06-15 |
PrS
Proposed sale
|
Officer
Officer
|
5,342
4.81
US$25,695
|
5,342
|
4.81
|
US$25,695
|
|
|
2026-06-15 |
2026-06-15 |
PrS
Proposed sale
|
Officer
Officer
|
7,556
4.81
US$36,344
|
7,556
|
4.81
|
US$36,344
|
|
|
2026-06-11 |
2026-06-11 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
7,289
-0.3%
4.91
US$35,789
|
7,289
-0.3%
|
4.91
|
US$35,789
|
|
|
2026-06-11 |
2026-06-11 |
PrS
Proposed sale
|
Officer
Officer
|
7,289
4.89
US$35,643
|
7,289
|
4.89
|
US$35,643
|
|
|
2026-06-11 |
2026-06-11 |
PrS
Proposed sale
|
Officer
Officer
|
7,289
4.89
US$35,643
|
7,289
|
4.89
|
US$35,643
|
|
|
2026-05-28 |
2026-05-28 |
PlS
Planned sale
|
CEO, Counterpart Health
Officer
|
220,426
-13.7%
3.99
US$879,500
|
220,426
-13.7%
|
3.99
|
US$879,500
|
|